Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
9.97
+0.13 (1.32%)
At close: May 19, 2025, 4:00 PM
9.87
-0.10 (-1.00%)
Pre-market: May 20, 2025, 9:21 AM EDT
Septerna Employees
Septerna had 75 employees as of December 31, 2024.
Employees
75
Change
n/a
Growth
n/a
Revenue / Employee
$13,027
Profits / Employee
-$1,054,773
Market Cap
444.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
SEPN News
- 3 days ago - Septerna: Novo's Investment In Incretin Program Intrigues - One For The Watchlist - Seeking Alpha
- 3 days ago - Septerna: Deal With Novo Nordisk Is A Game Changer While It Still Trades Well Below Net Cash - Seeking Alpha
- 4 days ago - Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 days ago - Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs - Benzinga
- 6 days ago - Novo Nordisk and Septerna Collaborate on Oral Medicines for Obesity and Other Diseases - WSJ
- 6 days ago - Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments - Reuters
- 6 days ago - Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases - GlobeNewsWire
- 7 weeks ago - Biotech Stocks Q1 2025 Recap: Winners And Underperformers - Seeking Alpha